If you liked this article you might like

Synthetic Biologics Targeting IBS Cause, Not Just Treatment
2016 Will Be Big in Battle Against IBS Says Synthetic Biologics CEO
Synthetic Biologics (SYN) Stock Tanks After Pricing Secondary Offering